BioMarin Pharmaceutical Inc. provided earnings guidance for the year 2024. For the year, the company expects total revenues of $2,700 million to $2,800 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
81.83 USD | -0.91% | -1.80% | -15.13% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.13% | 15.68B | |
-3.64% | 89.33B | |
+4.08% | 41.19B | |
-15.09% | 31.87B | |
+53.68% | 24.52B | |
-8.63% | 12.34B | |
-40.39% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B | |
-6.45% | 7.52B |
- Stock Market
- Equities
- BMRN Stock
- News BioMarin Pharmaceutical Inc.
- BioMarin Pharmaceutical Inc. Provides Earnings Guidance for the Year 2024